Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Antibodies to Digoxin for Bipolar Disorder.

Trial Profile

Antibodies to Digoxin for Bipolar Disorder.

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Jun 2013

At a glance

  • Drugs Anti-digoxin polyclonal antibody (Primary)
  • Indications Bipolar disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 15 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Feb 2009 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
    • 15 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top